Caerphilly, United Kingdom

Christopher John Davies

USPTO Granted Patents = 6 


Average Co-Inventor Count = 1.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Energlyn Park, GB (1998 - 1999)
  • Caerphilly, GB (1998 - 2000)
  • Mid Glamorgan, GB (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article highlighting the achievements of inventor Christopher John Davies from Caerphilly, GB.

Title: The Innovative Journey of Christopher John Davies: Shaping Future Technologies

Introduction:

Christopher John Davies stands as a beacon of innovation, inspiring others to think outside the box and push the limits of what is possible. His relentless dedication to the world of inventions continues to shape the future of technology and pave the way for a more sustainable tomorrow.

Latest Patents:

Christopher John Davies has contributed significantly to the field of antenatal risk assessment screening for pregnancy abnormalities. His latest patents include innovative methods for antenatal screening for chromosomal abnormalities using markers such as dimeric inhibin and free beta subunit of human chorion gonadotropin.

Career Highlights:

Currently working at Johnson & Johnson Clinical Diagnostics, Inc., Christopher John Davies has amassed a total of 4 patents, showcasing his expertise and commitment to advancing healthcare technologies. His work focuses on improving antenatal screening processes and enhancing the accuracy of chromosomal abnormality detection in pregnant women.

Collaborations:

Throughout his career, Christopher John Davies has collaborated with industry experts such as Andrew Jonathan Beard and Adrian Charles Dawkes. These collaborations have allowed him to combine his innovative ideas with the expertise of his peers, resulting in groundbreaking inventions that contribute to the advancement of medical diagnostics.

Conclusion:

In conclusion, Christopher John Davies' pioneering work in the field of antenatal screening for pregnancy abnormalities highlights his dedication to innovation and technological advancement. His contributions continue to inspire others to push boundaries and explore new possibilities in the ever-evolving landscape of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…